Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of sickle cell disease (SCD) as it improves treatment outcomes. However, despite the benefits of HU, its uptake among SCD patients in Nigeria remains low.Objective: This study aimed to assess the perception and experien...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Reuben Ikechukwu Chianumba, Akinyemi O. D. Ofakunrin, Jack Morrice, Olaniyi Olanrewaju, Oluseyi Oniyangi, Aisha Kuliya-Gwarzo, Uche Nnebe-Agumadu, Hezekiah Alkali Isa, Obiageli Eunice Nnodu
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2022-03-01
Σειρά:	Frontiers in Genetics
Θέματα:	sickle cell disease patients perception patients experience Nigeria hydroxyurea
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fgene.2022.826132/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!